Bio-Rad Laboratories Pioneer Antibody Discovery Platform

Wednesday, 16 November, 2022 | Supplied by: Bio-Rad Laboratories Pty Ltd


Bio-Rad Laboratories has launched its Pioneer Antibody Discovery Platform, an antibody discovery service specifically designed to develop best-in-class biologic candidates.

The platform features a state-of-the-art phage display library engineered to include more than 200 billion unique sequences and capable of identifying high-affinity antibody candidates using the company’s SpyDisplay selection technology. The antibody library is optimised for candidates that are suitable for drug development.

Tailored to each client’s specific requirements, the platform uses TrailBlazer technology to provide prototypes of therapeutic antibodies in a multitude of formats for streamlined lead identification. Final IgG antibodies will be delivered functionally characterised with a complete data package and sequences. Users will have exclusivity and ownership of antibody sequences.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers

The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated...

RevMAb Biosciences histone family protein monoclonal antibodies

RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...

Biosensis MAP2 antibodies

Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd